What factors influence your decision to initiate antifungal treatment in asymptomatic lung transplant recipients colonized with Aspergillus?  

My main driver for using Aspergillus treatment/prophylaxis for asymptomatic colonized patients is their level of immunosuppression; if they have received augmentation for rejection or because of a treatment for cancer, would strongly consider treatment; another reason would be if they are listed for...